Bronze
| Address | 43, Geodudanji 1-gil, Dongnae-myeon, Chungcheon-si, Gangwon-do, 24398, Korea | ||
|---|---|---|---|
| Telephone | +82-33-243-1400 | Fax | +82-33-243-9373 |
| Website | http://www.boditech.co.kr | sales@boditech.co.kr | |
Boditech Med Inc. has been developing products for in-vitro diagnostics and diagnostic reagents for the past 20 years by pursuing the company value called "Respect for Life".
In particular, about 50,000 units of ichroma™ readers are installed and operated worldwide, and ichroma™ CRP (C-Reactive Protein) has secured its largest market share in China, showing a unique competitiveness.
Boditech Med Inc. is leading the way in exploring new markets through the automation of on-site diagnosed immunodiagnostic devices and the development of new high-sensitive diagnostic reagents. We have built up our reputation successfully by carrying out various national R&D projects based on solid technology, experience, and human resources accumulated over the years.
In addition, Boditech Med Inc. is developing a smart production system that integrates digital technology and IT technology to flexibly manage the production scale. All employees of Boditech Med Inc. is making every effort with pride that we are the top leader of BT-IT convergence industry in Korea.
AFIAS-6 (AFIAS-automated fluorescent immunoassay system) is an automated fluorescent immunoassay system that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analyte. AFIAS all-in-one cartridges are designed to optimize the structure and operating principle of the reader. Its automated test process enables to carry out multiple simultaneous tests for six different samples. For some specified items such as TSH, CRP, PCT and HbA1c, small volume (10uL or 50uL) of whole blood from a finger or heel can be used for quantitative testing using a C-tip (capillary tip).
